AU2001271621A1 - Method of diagnosing, monitoring, staging, imaging and treating colon cancer - Google Patents

Method of diagnosing, monitoring, staging, imaging and treating colon cancer

Info

Publication number
AU2001271621A1
AU2001271621A1 AU2001271621A AU7162101A AU2001271621A1 AU 2001271621 A1 AU2001271621 A1 AU 2001271621A1 AU 2001271621 A AU2001271621 A AU 2001271621A AU 7162101 A AU7162101 A AU 7162101A AU 2001271621 A1 AU2001271621 A1 AU 2001271621A1
Authority
AU
Australia
Prior art keywords
staging
diagnosing
imaging
monitoring
colon cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271621A
Inventor
Roberto A. Macina
Rajeswari Pillai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of AU2001271621A1 publication Critical patent/AU2001271621A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001271621A 2000-06-28 2001-06-28 Method of diagnosing, monitoring, staging, imaging and treating colon cancer Abandoned AU2001271621A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21451500P 2000-06-28 2000-06-28
US60/214,515 2000-06-28
PCT/US2001/020724 WO2002000939A2 (en) 2000-06-28 2001-06-28 Method of diagnosing, monitoring, staging, imaging and treating colon cancer

Publications (1)

Publication Number Publication Date
AU2001271621A1 true AU2001271621A1 (en) 2002-01-08

Family

ID=22799368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271621A Abandoned AU2001271621A1 (en) 2000-06-28 2001-06-28 Method of diagnosing, monitoring, staging, imaging and treating colon cancer

Country Status (3)

Country Link
US (2) US6774223B2 (en)
AU (1) AU2001271621A1 (en)
WO (1) WO2002000939A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
EP1380644A1 (en) * 2002-07-08 2004-01-14 Kylix B.V. The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role
AU2003282785A1 (en) * 2002-08-26 2004-03-11 Case Western Reserve University Methods for treating patients and identifying therapeutics
DE60321356D1 (en) * 2002-08-30 2008-07-10 Oncotherapy Science Inc METHOD FOR DIAGNOSIS OF EGGSTOCK ENDOMETRIOSIS
WO2005014818A1 (en) 2003-08-08 2005-02-17 Perseus Proteomics Inc. Gene overexpressed in cancer
WO2007030531A2 (en) * 2005-09-06 2007-03-15 Molecular Image Inc. Reagents for testing and molecular imaging of liver cancer
US9134314B2 (en) 2007-09-06 2015-09-15 Case Western Reserve University Methods for diagnosing and treating cancers

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
DE69034078T2 (en) 1989-03-21 2004-04-01 Vical, Inc., San Diego Expression of exogenous polynucleotide sequences in vertebrates
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
EP0394827A1 (en) 1989-04-26 1990-10-31 F. Hoffmann-La Roche Ag Chimaeric CD4-immunoglobulin polypeptides
EP0871672A4 (en) 1995-05-05 1999-05-12 Human Genome Sciences Inc Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
US5705151A (en) 1995-05-18 1998-01-06 National Jewish Center For Immunology & Respiratory Medicine Gene therapy for T cell regulation
AU711346B2 (en) * 1995-06-06 1999-10-14 Human Genome Sciences, Inc. Colon specific gene and protein
US5733748A (en) * 1995-06-06 1998-03-31 Human Genome Sciences, Inc. Colon specific genes and proteins
JPH11515105A (en) * 1995-10-13 1999-12-21 マウント・サイナイ・ホスピタル・コーポレイション Activating a novel ligand regulatory pathway
US6225290B1 (en) 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation
EP1080227B1 (en) * 1998-05-21 2006-02-08 Diadexus, Inc. Method of diagnosing, monitoring, and staging colon cancer
JP2002525031A (en) * 1998-08-04 2002-08-13 ダイアデクスアス・インコーポレーテッド Novel methods of diagnosing, monitoring, staging, imaging and treating colorectal cancer
US6468758B1 (en) 1998-09-23 2002-10-22 Corixa Corporation Compositions and methods for ovarian cancer therapy and diagnosis
CA2345000A1 (en) * 1998-10-02 2000-04-13 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
EP1117791A2 (en) * 1998-10-05 2001-07-25 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
GB9905124D0 (en) * 1999-03-05 1999-04-28 Smithkline Beecham Biolog Novel compounds
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
WO2001055320A2 (en) 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1265919A2 (en) * 2000-03-23 2002-12-18 Incyte Genomics, Inc. G-protein associated molecules
AU2001251613A1 (en) 2000-04-14 2001-10-30 Millennum Pharmaceuticals, Inc. Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
CA2425827A1 (en) 2000-10-12 2002-04-18 Hyseq, Inc. Novel nucleic acids and polypeptides
AU2002211665B2 (en) 2000-10-12 2005-10-20 Exelixis, Inc. Human Ect2 and methods of use
JP4344519B2 (en) 2000-12-28 2009-10-14 旭化成ファーマ株式会社 NF-κB activating gene

Also Published As

Publication number Publication date
WO2002000939A3 (en) 2003-12-11
WO2002000939A2 (en) 2002-01-03
US20020081640A1 (en) 2002-06-27
US6774223B2 (en) 2004-08-10
US20040235040A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
AU2001251013A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1239874A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2001250932A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2002351405A1 (en) Method and apparatus for noise tomography
AU2002331842A1 (en) Method and apparatus for endobronchial diagnosis
AU2002243549A1 (en) Diagnostic and monitoring methods for cancer
GB0002051D0 (en) Cartridge, method of manufacturing the cartridge, and image-forming apparatus
AU2002312445A1 (en) Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression
EP1131095A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
AU2003304041A1 (en) Optical capsule and spectroscopic method for treating or diagnosing the intestinal tract
EP1267934A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
EP1107798A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2002348297A1 (en) Proteonomic methods for diagnosis and monitoring of breast cancer
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001289123A1 (en) Compounds and methods for diagnosing and treating amyloid-related conditions
EP1104486A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
AU2001249431A1 (en) Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
AU2002222944A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU6523901A (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1082460A4 (en) A novel method of diagnosing, monitoring, and staging prostate cancer
EP1126877A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer